Published

Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Universität Zürich, ZORA
Date: 2025-11-05
Source: OpenAlex
DOI: 10.5167/uzh-292276
PubMed: Unavailable

Authors

Milad Soltanzadeh Zheng Wang Shona G. Allohverdi Colleen E. Charlton André Schmidt Franz Xaver Vollenweider Andreea O. Diaconescu

Watch author

Derived topics and classifications

psilocybin Depression Anxiety Brain Imaging Pharmacology Mechanism of Action Receptor Pharmacology Default Mode Network Biomarkers Healthy Volunteers Other

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm2025-11-05

Related papers

Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24 Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18 Psychedelics produce enduring enhancement of reward responsiveness in male rats.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-07-10 Psychedelics, entactogens and psychoplastogens for depression and related disorders.British journal of pharmacology · 2026-07-01 Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’Behavioural Pharmacology · 2026-05-06 Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric DisordersPsychiatry and Clinical Psychopharmacology · 2026-03-30 Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-28